Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation
Yamazaki O et al. - In a case report of a 58-year-old Japanese man with primary systemic AL amyloidosis, it was concluded that in the future, there may be a time when clinical remission corresponds to histological remission. Methods- The case involved a 58-year-old Japanese man with primary systemic AL amyloidosis who achieved disappearance of proteinuria including Bence-Jones protein (λ-type) after 2 courses of VAD therapy (vincristine, doxorubicin, and dexamethasone) and subsequent high-dose melphalan, followed by autologous peripheral blood stem cell transplantation.< [more...]
|
|
|
